Award tenders
Awarded contractFrameworkNeg Wo CallSuppliesSpain

La contratación, mediante Acuerdo Marco con varios empresarios, del suministro sucesivo de los medicamentos de inmunoterapia oncológica para los centros hospitalarios del Servicio Gallego de Salud

8 suppliers awarded8 lots awarded€110.12M awarded

Buyer: SERGAS. Servicio Gallego de Salud. Dirección General de Recursos Económicos. Subdirección General de Inversiones / Santiago de Compostela, Spain

Published Jun 24, 2026Awarded May 07, 2026
Antineoplastic agents

Awarded value

€110.12M

Estimated value

€110.12M

Awarded at 100% of estimated value

Award date

May 07, 2026

Winners

8

Lots awarded

8

Award values

Notice total

€110.12M

Sum of lot awards

€50.05M

TED notice total and lot-level values do not exactly match.

Winners

€24.0M This contract

23 award notices36 awarded lots€58.84M total

1 lot

€13.0M This contract

8 award notices11 awarded lots€17.30M total

ROCHE FARMA SAU

RIBERA DEL LOIRA, 50, ESP

1 lot

€4.7M This contract

26 award notices60 awarded lots€64.07M total

€3.6M This contract

14 award notices18 awarded lots€8.97M total

MERCK, S.L.U.

Madrid, ESP

1 lot

€1.9M This contract

7 award notices8 awarded lots€5.85M total

1 lot

€1.5M This contract

2 award notices2 awarded lots€1.84M total

1 lot

€744,750 This contract

2 award notices2 awarded lots€1.05M total

1 lot

€566,546 This contract

25 award notices42 awarded lots€183.35M total

Lots awarded

LotTitleWinnerAward valueMain CPV
LOT-0007
Framework
Merck Sharp & Dohme de España,S.A.€24.0M

Antineoplastic agents (33652100)

LOT-0006
Framework
BRISTOL MYERS SQUIBB S A€13.0M

Antineoplastic agents (33652100)

LOT-0001
Framework
ROCHE FARMA SAU€4.7M

Antineoplastic agents (33652100)

LOT-0005
Framework
Astrazeneca Farmacéutica Spain, S.L.€3.6M

Antineoplastic agents (33652100)

LOT-0002
Framework
MERCK, S.L.U.€1.9M

Antineoplastic agents (33652100)

LOT-0003
Framework
REGENERON SPAIN, S.L.U.€1.5M

Antineoplastic agents (33652100)

LOT-0008
Framework
BEIGENE ESP, S.L.U.€744,750

Antineoplastic agents (33652100)

LOT-0004
Framework
GLAXOSMITHKLINE, S.A.€566,546

Antineoplastic agents (33652100)